Skip to main content

Advertisement

Table 1 Clinical characteristics of study subjects

From: Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans

N 585
Women/Men 422/163
Age (yr) 42 (31-52)
Body Mass Index (Kg/m 2 ) a 41 (36.5-47.5)
SBP (mm/Hg) 130 (120-140)
DBP (mm/Hg) 80 (80-90)
Triglycerides (mg/dL) 113 (81-157.2)
Total Cholesterol (mg/dL) 200 (178-227.1)
HDL Cholesterol (mg/dL) Male: 43 (38.1-49.1) Female: 50 (44-58.5)
LDL Cholesterol (mg/dL) 122 (103.5-146.2)
ALT (U/L) 28 (20.5-43)
AST (U/L) 20 (16-26)
Fasting blood glucose (mg/dL) 90 (82-99)
Fasting blood insulin (μU/mL) 24 (16.3-35)
HOMA-IR (U) 5.1 (3.4-8.4)
ISI (U) 2.1 (1.4-3.4)
Type 2 diabetes n (%) 40 (6.8)
  1. a BMI was calculated as body weight (kg)/height (m2). Values are medians and interquartile ranges. Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; ALT, alanine transaminase; AST, aspartate transaminase; HOMA-IR, homeostatic model assessment of insulin resistance; ISI, insulin sensitivity index.